Market Place
Sourcing Support
All News #Library
Biotech
Valion Bio Completes Transformation To Late-Stage Biopharma
24 Apr 2026 //
PR NEWSWIRE
Tivic Health To Present Entolimodtm As Radiation Countermeasure
15 Apr 2026 //
FIRSTWORD PHARMA
Tivic Gets Ukraine Ministry of Health Request for Entolimod Stock
31 Mar 2026 //
PHARMIWEB
Tivic CEO to Present at Emerging Growth April 2026 Virtual Event
27 Mar 2026 //
PHARMIWEB
Tivic Secures NIAID Agreement For Entolimod Evaluation
26 Mar 2026 //
PHARMIWEB
Tivic Reports Full Year 2025 Results
25 Mar 2026 //
PHARMIWEB
Tivic, BARDA Discuss Entolimod For Acute Radiation Syndrome
18 Feb 2026 //
PHARMIWEB
Tivic, BARDA Discuss Entolimod For Acute Radiation Syndrome
28 Jan 2026 //
PHARMIWEB
Tivic CEO To Present At Emerging Growth Conference
20 Jan 2026 //
PHARMIWEB
Tivic & BARDA to Meet on Entolimod for ARS Treatment
18 Nov 2025 //
PHARMIWEB
Tivic Reports Q1 2025 Financial Results and Business Updates
15 May 2025 //
BUSINESSWIRE
Tivic partners Scorpius BioManufacturing for FDA submission
14 May 2025 //
BUSINESSWIRE
Tivic Health Extends Worldwide License for TLR5 Agonist Entolimod
15 Apr 2025 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.